BUZZ-Alimera Sciences 下定决心起诉 ANI Pharma 以完成交易

Reuters
10 Sep 2024

((自动化翻译由路透提供,请见免责声明 ))

9月10日 - ** 眼科药物开发商Alimera Sciences 股价下跌16.67%,至4.61美元

** 公司在 (link) 提起诉讼,要求 ANI 制药公司 完成合并交易

** 该诉讼要求法院要求 ANI 履行其义务,按照协议的设想完成交易

** 两家公司于 6 月宣布 (link) 他们的协议,ALIM 的预付对价估值约为 3.81 亿美元。

** ALIM 今年以来的涨幅约为 6

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10